Orforglipron (6mg x 90 Capsules = 540mg)

$290.00

PRODUCT SHORT DESCRIPTION

The Orforglipron research platform delivers a highly stable, oral non-peptide matrix of 90 capsules, each containing 6mg of premium Orforglipron (540mg total mass). As a small-molecule GLP-1 receptor agonist, this encapsulated configuration is engineered for advanced laboratory investigations into metabolic flux, glycemic regulation, and continuous incretin pathway signaling without the risk of enzymatic degradation.

SKU: orforglipron-6mg-x-90-capsules-540mg Category:
Description

The Peptide Store presents Orforglipron as a highly stable, oral non-peptide small-molecule GLP-1 receptor agonist, manufactured to ≥98% purity and supplied in a convenient pre-measured capsule format for advanced laboratory research. This formulation is engineered for investigators conducting metabolic, glycemic, and incretin pathway studies requiring consistent, reproducible oral delivery simulations. For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.

Product Overview

Orforglipron represents a significant evolutionary milestone in incretin receptor research platforms. Unlike conventional GLP-1 receptor agonists (GLP-1RAs), which are inherently polymeric peptide structures susceptible to enzymatic degradation, Orforglipron is a fully synthetic, small-molecule, non-peptide compound. This distinct chemical classification grants the molecule natural resistance to gastric proteases and peptidases, making it an ideal candidate for standardized oral delivery simulations in laboratory settings. The Peptide Store supplies this cutting-edge research compound in a rigorously quality-controlled capsule format, providing laboratories with an exceptional reagent baseline for longitudinal, high-throughput metabolic screening and multi-cohort animal model investigations.

Peptide Structure & Amino Acid Sequence

Orforglipron is not a peptide in the classical sense and therefore does not possess a conventional amino acid sequence. It is a low-molecular-weight, orally bioavailable small molecule that selectively targets and activates the glucagon-like peptide-1 (GLP-1) receptor. Its non-peptidic backbone is specifically engineered to mimic the receptor-binding conformation of endogenous GLP-1 while bypassing the structural vulnerabilities associated with peptide-based agonists. This architectural distinction is central to its research utility, particularly in studies modeling oral incretin signaling dynamics without enzymatic interference.

Chemical & Physical Characteristics

  • Compound Class: Small-molecule, non-peptide GLP-1 receptor agonist
  • Molecular Form: Synthetic oral compound
  • Physical State: Encapsulated solid
  • Solubility Profile: Suitable for oral delivery simulation models; solubility characteristics consistent with small-molecule oral bioavailability research
  • Stability: Highly resistant to gastric protease and peptidase degradation due to non-peptidic backbone
  • Storage Compatibility: Stable under recommended controlled laboratory storage conditions

Purity & Analytical Verification (HPLC & MS)

Every batch of Orforglipron supplied by The Peptide Store undergoes rigorous analytical verification to confirm a minimum purity of ≥98%. High-performance liquid chromatography (HPLC) is employed to resolve and quantify the active compound against known reference standards, while mass spectrometry (MS) confirms molecular identity and rules out structural isomers or synthetic byproducts. These dual-verification protocols ensure that each capsule delivers a consistent, research-grade quantity of active compound, supporting the reproducibility and integrity of experimental datasets across multi-cohort and longitudinal study designs.

Quality Control & Lyophilization Integrity

Unlike lyophilized peptide powders that require reconstitution prior to use, Orforglipron is supplied in a pre-measured encapsulated format, eliminating reconstitution variability and reducing preparation-associated handling errors. Each capsule is individually filled to a precise 6mg active compound specification under controlled manufacturing conditions. The encapsulation process preserves compound integrity, protects against moisture ingress, and maintains chemical stability throughout the product’s shelf life. Batch-level quality control documentation is maintained to support audit trails and research compliance requirements.

Safety, Handling & Laboratory Precautions

Orforglipron is supplied exclusively for in vitro and in vivo preclinical research purposes. Researchers must handle this compound in accordance with applicable institutional biosafety guidelines and standard laboratory safety protocols. Appropriate personal protective equipment (PPE), including gloves, eye protection, and lab coats, should be worn at all times during handling. This compound must not be administered to humans or animals outside of formally approved preclinical research protocols. Keep out of reach of unauthorized personnel. Dispose of unused material in compliance with local regulatory waste disposal requirements.

Reconstitution, Packaging & Storage

Orforglipron is supplied in a sealed bottle containing 90 capsules, each pre-filled with 6mg of active compound. No reconstitution is required for capsule-format research applications. Store in a cool, dry environment away from direct light, heat, and humidity. Recommended storage temperature is consistent with standard controlled laboratory ambient conditions unless otherwise specified by your institutional protocols. Once opened, reseal the container tightly after each use to preserve capsule integrity and compound stability.

Intended Research Use & Market Positioning

Orforglipron is positioned as a premier research reagent for investigators studying GLP-1 receptor signaling, metabolic flux regulation, glycemic homeostasis, and oral incretin pharmacodynamics in preclinical models. Its small-molecule, non-peptide architecture makes it uniquely suited for oral bioavailability simulation studies, comparative receptor activation assays, and longitudinal metabolic screening programs. The Peptide Store offers this compound at a competitive best price, making it accessible to academic institutions, contract research organizations, and independent laboratories seeking high-quality, analytically verified GLP-1RA research tools.

Ordering, Availability & Fulfillment

Orforglipron (6mg x 90 Capsules) is available to buy online now through The Peptide Store. Orders are processed promptly, with fulfillment designed to meet the timelines of active research programs. Each order ships in secure, tamper-evident packaging to preserve compound integrity during transit. For bulk procurement inquiries, multi-unit discounts, or institutional purchase orders, contact The Peptide Store directly. Order now to secure your supply of this high-demand research compound at the best price available.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. Orforglipron is sold exclusively as a laboratory research reagent. The Peptide Store makes no representations regarding the safety, efficacy, or suitability of this compound for any application beyond formally approved preclinical research. Purchasers are solely responsible for ensuring compliance with all applicable local, national, and international regulations governing the procurement, handling, storage, and use of research chemicals. This product is not intended to diagnose, treat, cure, or prevent any disease or medical condition.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Orforglipron (6mg x 90 Capsules = 540mg)”

Your email address will not be published. Required fields are marked *

Shipping & Delivery